Health Cosmos Holdings Announces Strategic R&D Partnership with Cloudpharm P.C. to Study the Human Gastrointestinal Microbiome and Launch Related Products Targeting on Obesity and Other Gut-Related Disorders June 30, 2022
Health Cosmos Holdings Announces Strategic R&D Partnership with Cloudpharm P.C. to Study the Human Gastrointestinal Microbiome and Launch Related Products Targeting on Obesity and Other Gut-Related Disorders June 30, 2022
Health Cosmos Holdings to Launch Sky Premium Life Nutritional Supplements on Amazon in the United States June 2, 2022
Search
(NASDAQ:COSM)
